Answers are grounded in this paper and cite their sources.
Data on clinical, genetic, and immunological aspects of sixty patients with type 2 polyglandular autoimmune disease (PGAD) are presented. The literature on this is reviewed and discussed.
No takes yet. Share an insight, caveat, or question.
Betterle et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: